Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity

被引:493
作者
Mori, H
Hanada, R
Hanada, T
Aki, D
Mashima, R
Nishinakamura, H
Torisu, T
Chien, KR
Yasukawa, H
Yoshimura, A
机构
[1] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan
[2] Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 8390861, Japan
[3] Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[5] Kurume Univ, Dept Internal Med 3, Kurume, Fukuoka 8300011, Japan
[6] Kurume Univ, Inst Cardiovasc Res, Kurume, Fukuoka 8300011, Japan
关键词
D O I
10.1038/nm1071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leptin is an adipocyte-derived hormone that plays a key role in energy homeostasis, yet resistance to leptin is a feature of most cases of obesity in humans and rodents. In vitro analysis suggested that the suppressor of cytokine signaling-3 (Socs3) is a negative-feedback regulator of leptin signaling involved in leptin resistance. To determine the functional significance of Socs3 in vivo, we generated neural cell specific SOCS3 conditional knockout mice using the Cre-loxP system. Compared to their wild-type littermates, Socs3-deficient mice showed enhanced leptin-induced hypothalamic Stat3 tyrosine phosphorylation as well as pro-opiomelanocortin (POMC) induction, and this resulted in a greater body weight loss and suppression of food intake. Moreover, the Socs3-deficient mice were resistant to high fat diet induced weight gain and hyperleptinemia, and insulin-sensitivity was retained. These data indicate that Socs3 is a key regulator of diet-induced leptin as well as insulin resistance. Our study demonstrates the negative regulatory role of Socs3 in leptin signaling in vivo, and thus suppression of Socs3 in the brain is a potential therapy for leptin-resistance in obesity.
引用
收藏
页码:739 / 743
页数:5
相关论文
共 29 条
[1]   Leptin [J].
Ahima, RS ;
Flier, JS .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :413-437
[2]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[3]   STAT3 signalling is required for leptin regulation of energy balance but not reproduction [J].
Bates, SH ;
Stearns, WH ;
Dundon, TA ;
Schubert, M ;
Tso, AWK ;
Wang, YP ;
Banks, AS ;
Lavery, HJ ;
Haq, AK ;
Maratos-Flier, E ;
Neel, BG ;
Schwartz, MW ;
Myers, MG .
NATURE, 2003, 421 (6925) :856-859
[4]   Identification of SOCS-3 as a potential mediator of central leptin resistance [J].
Bjorbaek, C ;
Elmquist, JK ;
Frantz, JD ;
Shoelson, SE ;
Flier, JS .
MOLECULAR CELL, 1998, 1 (04) :619-625
[5]   SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985 [J].
Bjorbæk, C ;
Lavery, HJ ;
Bates, SH ;
Olson, RK ;
Davis, SM ;
Flier, JS ;
Myers, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40649-40657
[6]   Role of brain insulin receptor in control of body weight and reproduction [J].
Brüning, JC ;
Gautam, D ;
Burks, DJ ;
Gillette, J ;
Schubert, M ;
Orban, PC ;
Klein, R ;
Krone, W ;
Müller-Wieland, D ;
Kahn, CR .
SCIENCE, 2000, 289 (5487) :2122-2125
[7]   Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor [J].
Carpenter, LR ;
Farruggella, TJ ;
Symes, A ;
Karow, ML ;
Yancopoulos, GD ;
Stahl, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6061-6066
[8]   Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B [J].
Cheng, A ;
Uetani, N ;
Simoncic, PD ;
Chaubey, VP ;
Lee-Loy, A ;
McGlade, CJ ;
Kennedy, BP ;
Tremblay, ML .
DEVELOPMENTAL CELL, 2002, 2 (04) :497-503
[9]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[10]   Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes [J].
Ebihara, K ;
Ogawa, Y ;
Masuzaki, H ;
Shintani, M ;
Miyanaga, F ;
Aizawa-Abe, M ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Gavrilova, O ;
Reitman, ML ;
Nakao, K .
DIABETES, 2001, 50 (06) :1440-1448